日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Serial Llama Immunization with Various SARS-CoV-2 RBD Variants Induces Broad Spectrum Virus-Neutralizing Nanobodies

使用各种 SARS-CoV-2 RBD 变体对骆驼进行连续免疫可诱导广谱病毒中和纳米抗体

Pavel P Solodkov, Alexander M Najakshin, Nikolai A Chikaev, Sergey V Kulemzin, Ludmila V Mechetina, Konstantin O Baranov, Sergey V Guselnikov, Andrey A Gorchakov, Tatyana N Belovezhets, Anton N Chikaev, Olga Y Volkova, Alexander G Markhaev, Yulia V Kononova, Alexander Y Alekseev, Marina A Gulyaeva, 

Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection

与再接种疫苗或再感染相比,Gam-COVID-Vac 疫苗接种和自然 SARS-CoV-2 感染产生的混合免疫力对 Omicron 谱系 VOC 具有更广泛的中和活性

Sergey V Kulemzin, Sergey V Guselnikov, Boris G Nekrasov, Svetlana V Molodykh, Irina N Kuvshinova, Svetlana V Murasheva, Tatyana N Belovezhets, Andrey A Gorchakov, Anton N Chikaev, Nikolai A Chikaev, Olga Y Volkova, Anna A Yurina, Alexander M Najakshin, Alexander V Taranin

Prevalence of Trypanosoma cruzi, the Etiologic Agent of Chagas Disease, Infection in Texas Skunks (Mammalia: Mephitidae)

德克萨斯州臭鼬(哺乳纲:臭鼬科)中克氏锥虫(恰加斯病病原体)感染的流行情况

Gulas-Wroblewski, Bonnie E; Gorchakov, Rodion; Kairis, Rebecca B; Dowler, Robert C; Murray, Kristy O

Comparative Pre-Clinical Analysis of CD20-Specific CAR T Cells Encompassing 1F5-, Leu16-, and 2F2-Based Antigen-Recognition Moieties

包含基于 1F5、Leu16 和 2F2 的抗原识别部分的 CD20 特异性 CAR T 细胞的比较临床前分析

Tatyana Belovezhets, Sergey Kulemzin, Olga Volkova, Alexander Najakshin, Alexander Taranin, Andrey Gorchakov

Anti-Ad26 humoral immunity does not compromise SARS-COV-2 neutralizing antibody responses following Gam-COVID-Vac booster vaccination

接种 Gam-COVID-Vac 加强疫苗后,抗 Ad26 体液免疫不会影响 SARS-CoV-2 中和抗体反应。

Maria G Byazrova ,Ekaterina A Astakhova ,Aygul R Minnegalieva ,Maria M Sukhova ,Artem A Mikhailov ,Alexey G Prilipov ,Andrey A Gorchakov ,Alexander V Filatov

Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon Ex Vivo Restimulation

接种 Sputnik V 疫苗后诱导产生的记忆 B 细胞在体外再次刺激后可产生 SARS-CoV-2 中和抗体

Maria G Byazrova ,Sergey V Kulemzin ,Ekaterina A Astakhova ,Tatyana N Belovezhets ,Grigory A Efimov ,Anton N Chikaev ,Ilya O Kolotygin ,Andrey A Gorchakov ,Alexander V Taranin ,Alexander V Filatov

Functional Profiling of In Vitro Reactivated Memory B Cells Following Natural SARS-CoV-2 Infection and Gam-COVID-Vac Vaccination

自然感染 SARS-CoV-2 和接种 Gam-COVID-Vac 疫苗后体外再激活记忆 B 细胞的功能分析

Ekaterina A Astakhova, Maria G Byazrova, Gaukhar M Yusubalieva, Sergey V Kulemzin, Natalia A Kruglova, Alexey G Prilipov, Vladimir P Baklaushev, Andrey A Gorchakov, Alexander V Taranin, Alexander V Filatov

Fuzzy Information Discrimination Measures and Their Application to Low Dimensional Embedding Construction in the UMAP Algorithm

模糊信息判别度量及其在UMAP算法中低维嵌入构造中的应用

Demidova, Liliya A; Gorchakov, Artyom V

VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages

VH3-53/66 类 RBD 特异性人单克隆抗体 iB20 显示出针对新出现的 SARS-CoV-2 谱系的交叉中和活性

Sergey V Kulemzin, Maria V Sergeeva, Konstantin O Baranov, Andrey A Gorchakov, Sergey V Guselnikov, Tatyana N Belovezhets, Olga Yu Volkova, Alexander M Najakshin, Nikolai A Chikaev, Daria M Danilenko, Alexander V Taranin

Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern

分离出一组可中和 SARS-CoV-2 及其相关病毒变体的超强人类抗体

Andrey A Gorchakov #, Sergey V Kulemzin #, Sergey V Guselnikov #, Konstantin O Baranov #, Tatyana N Belovezhets, Ludmila V Mechetina, Olga Yu Volkova, Alexander M Najakshin, Nikolai A Chikaev, Anton N Chikaev, Pavel P Solodkov, Victor F Larichev, Marina A Gulyaeva, Alexander G Markhaev, Yulia V Kono